Pharmabiz2h
DoP’s targeted policy interventions adds heft to state funded Gujarat’s Nagalpar Park: Dr H G Koshia
DoP’s targeted policy interventions adds heft to state funded Gujarat’s Nagalpar Park: Dr H G Koshia: Shardul Nautiyal, Mumbai Monday, December 16, 2024, 08:00 Hrs [IST] The D ...
Pharmabiz1h
CPHI Milan sees record rise in attendance, increased dealmaking
CPHI Milan – the world’s largest pharma event – hosted last month in Milan saw a new record attendance of 59,000 pharma executives buoyed by returning confidence and increased dealmaking on site. The ...
Pharmabiz2h
Stringent action will be taken against sale of habit-forming drugs without prescription: New TN drug controller
The new director of the drug control administration (DCA) in Tamil Nadu, M Sridhar, said steps will be taken to check sale of habit-forming drugs and abortion pills without prescription in the state.
Pharmabiz2h
India needs new drugs, improve infection control practices to thwart AMR: Dr Prabhu Vinayagam
India needs new drugs, improve infection control practices to thwart AMR: Dr Prabhu Vinayagam: Nandita Vijayasimha Bengaluru Monday, December 16, 2024, 08:00 Hrs [IST] India needs ...
Pharmabiz2h
NCCE proposes amendment of CE Act to allow physiotherapists to own and run clinics
NCCE proposes amendment of CE Act to allow physiotherapists to own and run clinics: Gireesh Babu, New Delhi Monday, December 16, 2024, 08:00 Hrs [IST] The National Council for Cli ...
Pharmabiz2h
Total sales under PLI scheme for pharmaceuticals in H1FY25 at Rs. 11,853 crore
The total sales of high value pharmaceutical products including biopharmaceuticals, complex generic drugs and patented drugs among others manufactured under the production linked incentive (PLI) ...
Pharmabiz1d
AIIMS signs MoU with Wipro GE Healthcare to establish ‘AI Health Innovations Hub’ to advance precision health solutions for India & the world
AIIMS signs MoU with Wipro GE Healthcare to establish ‘AI Health Innovations Hub’ to advance precision health solutions for India & the world: Our Bureau, Mumbai Saturday, Dec ...
Pharmabiz1d
US FDA accepts Ascendis’ sBLA of TransCon for review to treat adults with growth hormone deficiency
Ascendis Pharma A/S, a global pharma company applying its innovative TransCon technology platform to build a leading and fully integrated biopharma company focused on making a meaningful difference in ...
Pharmabiz1d
Roche’s new and updated molecular cobas 6800/8800 systems receives CE certification
Roche’s new and updated molecular cobas 6800/8800 systems receives CE certification: Basel Saturday, December 14, 2024, 15:00 Hrs [IST] Roche announced the CE certification of t ...
Pharmabiz2d
Health and wellness industry set to witness a transformative innovation with the launch of Auffüllen
Health and wellness industry set to witness a transformative innovation with the launch of Auffüllen: Our Bureau, Mumbai ...
Pharmabiz1d
Bayer initiates phase I study with SOS1 inhibitor, BAY3498264 in patients with advanced KRAS-mutated tumours
Bayer initiates phase I study with SOS1 inhibitor, BAY3498264 in patients with advanced KRAS-mutated tumours: Berlin Saturday, December 14, 2024, 13:00 Hrs [IST] Bayer announced i ...
Pharmabiz1d
BeiGene enters global licensing agreement CSPC Zhongqi Pharmaceutical for MAT2A inhibitor for solid tumours
BeiGene enters global licensing agreement CSPC Zhongqi Pharmaceutical for MAT2A inhibitor for solid tumours: San Mateo, California Saturday, December 14, 2024, 12:00 Hrs [IST] Bei ...